Boundedness of Integral Operators With Kernels From the Class On±ν,μ, n ≥ 0, in Lebesgue Spaces With Measures
Journal of Function Spaces · 2026-01 · 2026 (1)
DOI: 10.1155/jofs/8151925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Function Spaces, online erschienen am 30.10.2026. Verfasst von Ryskul Oinarov und 1 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science of the Republic of Kazakhstan.
Abstract (Originalsprache)
In recent years, weighted inequalities for quasilinear integral operators with iterative structures have been extensively studied. The analysis reduces these inequalities to the study of Volterra operators with increasingly complex kernels and measures. This paper introduces a broader class of kernels, extending existing conditions. Key properties of these kernels are explored, and new boundedness criteria for the corresponding operators in weighted Lebesgue spaces are established. These results provide a foundation for solving inequalities involving quasilinear integral operators and have applications in the analysis of bilinear operators.
Förderung
- Ministry of Education and Science of the Republic of Kazakhstan
Zitieren
APA
Oinarov, R., & Shalginbayeva, S. (2026). Boundedness of Integral Operators With Kernels From the Class On±ν,μ, n ≥ 0, in Lebesgue Spaces With Measures. Journal of Function Spaces, 2026(1). https://doi.org/10.1155/jofs/8151925
Vancouver
Oinarov R, Shalginbayeva S. Boundedness of Integral Operators With Kernels From the Class On±ν,μ, n ≥ 0, in Lebesgue Spaces With Measures. Journal of Function Spaces. 2026;2026(1). doi:10.1155/jofs/8151925
BibTeX
@article{Oinarov2026,
author = {Oinarov, Ryskul and Shalginbayeva, Saltanat},
title = {Boundedness of Integral Operators With Kernels From the Class On±ν,μ, n ≥ 0, in Lebesgue Spaces With Measures},
journal = {Journal of Function Spaces},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jofs/8151925}
}
EUVIMED